Zonisamide
- Product NDC
- 43063-932
- 11-digit product format
- 430630932
- Labeler code
- 43063
- Product ID
- 43063-932_e6da992a-7745-191e-e053-2995a90a66d0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Zonisamide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA077634
- Marketing category
- ANDA
- Marketing start
- 2006-03-17
- Marketing end
- 0000-00-00
- Substance
- ZONISAMIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-932-30 | 43063093230 | 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-932-30) | 30 capsule | 2019-01-14 | 0000-00-00 | No | No | Current |